VIPoma other imaging findings: Difference between revisions
Jump to navigation
Jump to search
Madhu Sigdel (talk | contribs) No edit summary |
Madhu Sigdel (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}{{AE}}{{MSI}}{{PSD}} | {{CMG}}{{AE}}{{MSI}}{{PSD}} | ||
==Overview== | ==Overview== | ||
Other imaging studies for VIPoma include [[somatostatin]] receptor scintigraphy and PET scan. | Other imaging studies for VIPoma include [[somatostatin]] receptor [[Nuclear medicine|scintigraphy]] and [[Positron emission tomography|PET]] scan using radiolabeled somatostatin analogs. | ||
==Other Imaging Findings== | ==Other Imaging Findings== | ||
[[Somatostatin]] receptor [[scintigraphy]] (Octreoscan) is used to localise the [[tumor]], which is usually [[metastasis|metastatic]] at presentation. | [[Somatostatin]] receptor [[scintigraphy]] (Octreoscan) is used to localise the [[tumor]], which is usually [[metastasis|metastatic]] at presentation. Most of pancreatic [[Neuroendocrine tumors|NET]] express high levels of [[somatostatin]] receptors. | ||
<gallery>Image:PET CT.jpg|PET-CT with MBq 68-Gallium-DOTATOC showing enhancement of multiple lesions in the right lobe of the liver (upper image) and a slight enhancement in the caudal pancreas (lower image).<ref name="MüllerKupka2012">{{cite journal|last1=Müller|first1=Sven|last2=Kupka|first2=Susan|last3=Königsrainer|first3=Ingmar|last4=Northoff|first4=Hinnak|last5=Sotlar|first5=Karl|last6=Bock|first6=Thomas|last7=Kandolf|first7=Reinhard|last8=Traub|first8=Frank|last9=Königsrainer|first9=Alfred|last10=Zieker|first10=Derek|title=MSH2 and CXCR4 involvement in malignant VIPoma|journal=World Journal of Surgical Oncology|volume=10|issue=1|year=2012|pages=264|issn=1477-7819|doi=10.1186/1477-7819-10-264}}</ref> | <gallery>Image:PET CT.jpg|PET-CT with MBq 68-Gallium-DOTATOC showing enhancement of multiple lesions in the right lobe of the liver (upper image) and a slight enhancement in the caudal pancreas (lower image).<ref name="MüllerKupka2012">{{cite journal|last1=Müller|first1=Sven|last2=Kupka|first2=Susan|last3=Königsrainer|first3=Ingmar|last4=Northoff|first4=Hinnak|last5=Sotlar|first5=Karl|last6=Bock|first6=Thomas|last7=Kandolf|first7=Reinhard|last8=Traub|first8=Frank|last9=Königsrainer|first9=Alfred|last10=Zieker|first10=Derek|title=MSH2 and CXCR4 involvement in malignant VIPoma|journal=World Journal of Surgical Oncology|volume=10|issue=1|year=2012|pages=264|issn=1477-7819|doi=10.1186/1477-7819-10-264}}</ref> | ||
</gallery> | </gallery> | ||
Revision as of 00:36, 5 January 2018
|
VIPoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
VIPoma other imaging findings On the Web |
|
American Roentgen Ray Society Images of VIPoma other imaging findings |
|
Risk calculators and risk factors for VIPoma other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Madhu Sigdel M.B.B.S.[2]Parminder Dhingra, M.D. [3]
Overview
Other imaging studies for VIPoma include somatostatin receptor scintigraphy and PET scan using radiolabeled somatostatin analogs.
Other Imaging Findings
Somatostatin receptor scintigraphy (Octreoscan) is used to localise the tumor, which is usually metastatic at presentation. Most of pancreatic NET express high levels of somatostatin receptors.
-
![PET-CT with MBq 68-Gallium-DOTATOC showing enhancement of multiple lesions in the right lobe of the liver (upper image) and a slight enhancement in the caudal pancreas (lower image).[1]](/images/f/f3/PET_CT.jpg)
PET-CT with MBq 68-Gallium-DOTATOC showing enhancement of multiple lesions in the right lobe of the liver (upper image) and a slight enhancement in the caudal pancreas (lower image).[1]
![PET-CT with MBq 68-Gallium-DOTATOC showing enhancement of multiple lesions in the right lobe of the liver (upper image) and a slight enhancement in the caudal pancreas (lower image).[1]](/index.php/File:PET_CT.jpg)
References
- ↑ Müller, Sven; Kupka, Susan; Königsrainer, Ingmar; Northoff, Hinnak; Sotlar, Karl; Bock, Thomas; Kandolf, Reinhard; Traub, Frank; Königsrainer, Alfred; Zieker, Derek (2012). "MSH2 and CXCR4 involvement in malignant VIPoma". World Journal of Surgical Oncology. 10 (1): 264. doi:10.1186/1477-7819-10-264. ISSN 1477-7819.